1
|
Hupertan V, Beley S, Dumonceau O, Haab F. Vasectomie sans bistouri : complications précoces et tardives. expérience d’un seul opérateur après 380 procédures. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
2
|
Leroy C, Treluyer L, Hellmann R, Cléry R, Haab F, Parc Y. Retour d’expérience sur la cellule régionale d’appui à la régulation des lits de réanimation Covidréa pendant la crise Covid-19. Ann Fr Med Urgence 2020. [DOI: 10.3166/afmu-2020-0278] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
La disponibilité des lits de réanimation a été un enjeu majeur de la gestion de la crise Covid-19, imposant aux acteurs régionaux de construire une réponse coordonnée et novatrice pour apporter une réponse en termes de recherche de place. Dans la région Île-de-France, la mise en place du dispositif a été constituée par deux mesures : la refonte du répertoire opérationnel des ressources (ROR) et la création d’une cellule d’appui régionale (Covidréa) comportant des cellules médicale et administrative. Les opérateurs de la cellule médicale étaient des chirurgiens volontaires sous la supervision d’un médecin urgentiste, chargés des actions de recherche et de régulation des demandes. La cellule administrative a vérifié la pertinence des informations du ROR sur un rythme pluriquotidien. La mobilisation des acteurs locaux (anesthésistes et réanimateurs) a permis d’obtenir des données actualisées du ROR quasiment en temps réel. La crise sanitaire Covid-19 a mis en lumière les faiblesses des systèmes d’information, particulièrement la connaissance de la disponibilité en lits de réanimation en temps réel. Une démarche collective pour construire de nouveaux outils de pilotage adaptés au quotidien, dans le cadre des tensions hivernales (bronchiolite, grippe) ou saisonnières (canicule), et la gestion des situations sanitaires exceptionnelles est impérative. Il est nécessaire d’intégrer cette fonction dans la mission des Samu départementaux en temps ordinaire et des Samu zonaux en temps de crise, en particulier dans la logique de construction du futur service d’accès aux soins (SAS).
Collapse
|
3
|
Cornu JN, Amarenco G, Bruyere F, Chartier-Kastler E, Fatton B, Grise P, Haab F, Bourouina R. [Prevalence and initial management of overactive bladder in France: A cross-sectional study]. Prog Urol 2016; 26:415-24. [PMID: 27108102 DOI: 10.1016/j.purol.2016.04.002] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2016] [Revised: 03/31/2016] [Accepted: 04/01/2016] [Indexed: 01/16/2023]
Abstract
AIMS To determine the prevalence of overactive bladder (OAB) syndrome in France and gather data about initial patient trajectories in the healthcare system. METHODS A dedicated questionnaire (41 questions) has been sent to a 12,000 sample of people representative of the global population. The following data were investigated: social and demographic features, medical history, Urinary Symptom Profile questionnaire, bother, history of symptoms, care seeking and treatments received. Patient were considered having OAB in case if presenting at least two episodes of urgency per week, or being under treatment of OAB. OAB prevalence was the main outcome, and associated factors were characterized by univariate and multivariate analysis. RESULTS Based on 8842 available questionnaires, the global prevalence of OAB was estimated to be 14.4%. Prevalence was significantly higher in women, older age groups, as well as obesity, irritable bowel syndrome, urinary tract infections, enuresia, constipation, anxiety/depression, neurological diseases, sleep apnea syndrome, asthma, chronic obstructive pulmonary disease, diabetes and hypertension. Only 34.6% of patients with OAB had visited a health practitioner for this problem. General practitioners were most frequently implicated in patient primary care and evaluation. Seventy-two percent of patients with OAB had had additional investigations (mostly a urine culture) and only 6% of patients had to complete a bladder diary. The most frequent treatment option was oral antimuscarinics. Physical therapy and rehabilitation have been prescribed in 26% of cases, as well as dietary advice. CONCLUSIONS OAB is a frequent syndrome. Its prevalence increases with age, and OAB frequently concern elderly frail people with many other associated diseases. LEVEL OF EVIDENCE 3.
Collapse
Affiliation(s)
- J-N Cornu
- Chirurgie urologique, université de Rouen, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France.
| | - G Amarenco
- Sorbonne universités, UPMC université Paris 06, GRC 01, GREEN, Group of Clinical Research in Neuro-Urology, 75005 Paris, France; Service de neuro-urologie et d'explorations périnéales, hôpital Tenon, AP-HP, 75020 Paris, France
| | - F Bruyere
- Chirurgie urologique, CHRU Le Bretonneau, 2, boulevard Tonnelé, 37000 Tours, France
| | - E Chartier-Kastler
- Faculté de médecine Pierre-et-Marie-Curie, Paris 6, hôpital universitaire Pitié-Salpetrière, AP-HP, 83, boulevard de l'Hôpital, 75013 Paris, France
| | - B Fatton
- Gynécologie/obstétrique, CHU Caremeau, 4, rue Professeur-Robert-Debré, 30029 Nîmes, France
| | - P Grise
- Chirurgie urologique, université de Rouen, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France
| | - F Haab
- Centre urologie Paris Opéra, 75009 Paris, France
| | - R Bourouina
- Astellas Pharma, 26, quai Michelet, CS 90067, 92309 Levallois-Perret cedex, France
| |
Collapse
|
4
|
Najdawi M, Benbouzid S, Audouin M, Terrasa J, Peyrat L, Ciofu C, Haab F, Cornu J. Bandelette Advance™ pour incontinence urinaire d’effort masculine : résultats à long terme. Prog Urol 2015; 25:840. [DOI: 10.1016/j.purol.2015.08.248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
5
|
Affiliation(s)
- J Cornu
- Hôpital Tenon, Paris, France
| | | | | | | | - F Haab
- Hôpital Tenon, Paris, France
| |
Collapse
|
6
|
Léon P, Kloutidis N, Calves J, Compérat E, Funes de la Vega M, Cancel Tassin G, Ciofu C, Haab F, Fournier G, Korman P, Valeri A, Rouprêt M, Cormier L, Larré S, Cussenot O. [Not Available]. Prog Urol 2015; 24:784. [PMID: 26461534 DOI: 10.1016/j.purol.2014.08.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- P Léon
- Service d'urologie et andrologie, hôpital de la Pitié-Salpêtrière, Paris, France
| | - N Kloutidis
- Service d'urologie, CHU de Dijon, Dijon, France
| | - J Calves
- Service d'urologie, CHU de Brest, Brest, France
| | - E Compérat
- Service d'anatomopathologie, hôpital de la Pitié-Salpêtrière, CeRePP, Paris, France
| | | | - G Cancel Tassin
- GRC-N(o)5 Institut universitaire de cancérologie Paris 6 (urologie-anatomo-pathologie Pitié/Tenon), CeReSPP, Paris, France
| | - C Ciofu
- GRC-N(o)5 Institut universitaire de cancérologie Paris 6 (urologie-anatomo-pathologie Pitié/Tenon), CeReSPP, Paris, France
| | - F Haab
- GRC-N(o)5 Institut universitaire de cancérologie Paris 6 (urologie-anatomo-pathologie Pitié/Tenon), CeReSPP, Paris, France
| | - G Fournier
- Service d'urologie du CHU de Brest et CeRePP, Brest, France
| | - P Korman
- Myriad Genetics SAS, Issy les Moulineaux, France
| | - A Valeri
- Service d'urologie du CHU de Brest et CeRePP, Brest, France
| | - M Rouprêt
- GRC-N(o)5 Institut universitaire de cancérologie Paris 6 (urologie-anatomo-pathologie Pitié/Tenon), CeReSPP, Paris, France
| | - L Cormier
- Service d'urologie, CHU de Dijon, CeRePP, Dijon, France
| | - S Larré
- Service d'urologie, CHU de Reims, CeRePP, Reims, France
| | - O Cussenot
- GRC-N(o)5 Institut universitaire de cancérologie Paris 6 (urologie-anatomo-pathologie Pitié/Tenon), CeReSPP, Paris, France
| |
Collapse
|
7
|
Dariane C, Cornu JN, Esteve E, Cordel H, Egrot C, Traxer O, Haab F. [Fungal infections and ureteral material: How to manage?]. Prog Urol 2015; 25:306-11. [PMID: 25724861 DOI: 10.1016/j.purol.2015.01.015] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2014] [Revised: 01/16/2015] [Accepted: 01/24/2015] [Indexed: 11/18/2022]
Abstract
INTRODUCTION Urinary tract infections due to Candida species are mostly encountered in hospital environment. The management of candiduria on ureteral catheter is not consensual. The objective of our work was to make a review of medical literature related to definition, physiopathology, management and prevention of candiduria on ureteral catheter. MATERIAL AND METHODS The research was made on Medline using the following keywords: Candida; fungal; urinary tract infection; ureteral stent; ureteric stent; double-J pigtail. RESULTS The threshold defining candiduria is 10(5) CFU/mL. Candiduria corresponds to many different clinical presentations from colonization to candidemia. Species found are mostly Candida albicans (19-72%) and Candida glabrata (15.6-49.4%). The colonization of ureteral stent due to Candida is of 10% and comes with candiduria in 40% of the cases, due to the presence of biofilm. Prevention of infections on ureteral stents requires a regular change of material every 3-6 months depending on the patients risk groups. In case of symptomatic candiduria on ureteral stent, an anti-fungal therapy should be initiated 48 hours to 3 weeks before the change of the stent, in order to get a sterilization of urines and prevent the recolonization of the stent. Fluconazole is the drug of choice to use. CONCLUSION Colonization of ureteral stents due to Candida is common and can be responsible of symptomatic infection. Anti-fungal therapy should be introduced before the change of the stent but a consensual duration of treatment before surgery is not found in the literature.
Collapse
Affiliation(s)
- C Dariane
- Service d'urologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
| | - J-N Cornu
- Service d'urologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France
| | - E Esteve
- Service de maladies infectieuses, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France
| | - H Cordel
- Service de maladies infectieuses, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France
| | - C Egrot
- Service d'urologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France
| | - O Traxer
- Service d'urologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France
| | - F Haab
- Service d'urologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France
| |
Collapse
|
8
|
Gamé X, Karsenty G, Ruffion A, Amarenco G, Ballanger P, Chartier-Kastler E, Cosson M, Costa P, Fatton B, Deffieux X, Haab F, Hermieu JF, Le Normand L, Saussine C, Denys P. [Idiopathic overactive bladder and BOTOX(®): Literature review]. Prog Urol 2015; 25:461-73. [PMID: 25662706 DOI: 10.1016/j.purol.2015.01.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2014] [Accepted: 01/12/2015] [Indexed: 11/29/2022]
Abstract
AIM Systematically review literature on the efficacy and tolerability of botulinum toxin A (onabotulinumtoxineA, BOTOX(®), Allergan, CA, USA) in refractory idiopathic overactive bladder (iOAB) METHODS: Pubmed search on the efficacy, toxicity and adverse events of onabotulinumtoxinA in clinical trials only with level 1 and 2 evidence. RESULTS Eleven controlled randomised trials have been selected, of which 3 phase III trials. The studies published data of 1008 patients with refractory iOAB treated with onabotulinumtoxineA. In the phase II and III trials, doses from 50 U to 300 U have been evaluated; more than half of the patients (n = 676) with 100 U. In the 2 main phase III trials, onabotulinumtoxinA has demonstrated to be more efficient compared to placebo on continence, symptoms and quality of live (QoL). Urodynamic results, reported in the phase II trials, demonstrated higher changes compared to placebo only from dose 100 U on, although not always significant. Adverse events (urinary retention, dysuria, urinary tract infection) were easily treated and did not influence patient's QoL. CONCLUSION Intradetrusor injections of onabotulinumtoxinA (BOTOX(®)), a minimally-invasive procedure, seem to be efficient and well tolerated in the treatment of refractory iOAB.
Collapse
Affiliation(s)
- X Gamé
- Service d'urologie, hôpital de Rangueil, 1, avenue du Professeur-Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France
| | - G Karsenty
- Service de chirurgie urologique et transplantation rénale, CHU de la Conception, Aix-Marseille université, 147, boulevard Baille, 13005 Marseille, France
| | - A Ruffion
- Service d'urologie, centre hospitalier Lyon Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France
| | - G Amarenco
- Service de rééducation neuro-urologique, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
| | - P Ballanger
- Service d'urologie, hôpital Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France
| | - E Chartier-Kastler
- Service d'urologie, hôpital de la Pitié-Salpétrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France
| | - M Cosson
- Service de gynécologie, CHRU de Lille, rue Eugène-Avinée, 59037 Lille cedex, France
| | - P Costa
- Service d'urologie, CHRU Carémeau, rue du Professeur-Debré, 30029 Nîmes cedex 9, France
| | - B Fatton
- Service de gynécologie, CHRU Carémeau, rue du Professeur-Debré, 30029 Nîmes cedex 9, France
| | - X Deffieux
- Service de gynécologie-obstétrique, hôpital Antoine-Béclère, AP-HP, 157, rue de la Porte-Trivaux, 92140 Clamart, France
| | - F Haab
- Service d'urologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
| | - J-F Hermieu
- Service d'urologie, hôpital Bichat, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France
| | - L Le Normand
- Service d'urologie, Hôtel Dieu, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
| | - C Saussine
- Service d'urologie, CHU, 1, place de l'Hôpital, 67000 Strasbourg, France
| | - P Denys
- Service de médecine physique et de réadaptation, hôpital Raymond-Poincaré, AP-HP, 104, boulevard Raymond-Poincaré, 92380 Garches, France.
| |
Collapse
|
9
|
Bunn F, Kirby M, Pinkney E, Cardozo L, Chapple C, Chester K, Cruz F, Haab F, Kelleher C, Milsom I, Sievart KD, Tubaro A, Wagg A. Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. Int J Clin Pract 2015; 69:199-217. [PMID: 25495905 DOI: 10.1111/ijcp.12518] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/18/2014] [Accepted: 07/07/2014] [Indexed: 11/29/2022] Open
Abstract
OBJECTIVES To conduct a systematic review to determine whether there is an association between metabolic syndrome (MetS) and lower urinary tract symptoms (LUTS) or overactive bladder (OAB) in women. METHODS We systematically reviewed English language observational studies on the effect of MetS (or component factors) on the presence of OAB or LUTS in women. We searched PubMed, Web of Science and The Cochrane Library with no date restrictions, checked reference lists and undertook citation searches in PubMed and Google Scholar. Studies were assessed for risk of bias. Because of heterogeneity, results were not pooled, but are reported narratively. RESULTS Of 27 included studies, only three looked at the link between MetS and OAB. The rest looked at links between OAB and components of MetS such as obesity or insulin resistance (n = 10), between MetS and urinary symptoms (n = 3) and between urinary symptoms and components of MetS, such as obesity (n = 14). Evidence is currently limited, but it does suggest that there may be important links between MetS and OAB and components of MetS such as obesity. CONCLUSIONS The literature on MetS and OAB or LUTS in women is limited, and poor quality. However, the evidence available on obesity appears to support MetS as a contributor and predictor of LUTS in women. Many of the women with LUTS will be overweight and will have features of the MetS, if looked for. This provides not only an opportunity to encourage weight loss as an adjunct to therapy for the OAB symptoms but also a window of opportunity to address cardiovascular risk factors and prevent future cardiovascular morbidity and mortality.
Collapse
Affiliation(s)
- F Bunn
- Centre for Research in Primary and Community Care, University of Hertfordshire, Hatfield, Hertfordshire, UK
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Cornu J, Melot C, Benbouzid S, Peyrat L, Ciofu C, Haab F. Résultats à moyen et long terme de l’implantation de bandelette sous-uréthrale pour le traitement de l’incontinence d’effort non neurologique chez les patientes de moins de 40ans : une série rétrospective. Prog Urol 2014; 24:889. [DOI: 10.1016/j.purol.2014.08.231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
11
|
Cornu J, Hajji A, Benbouzid S, Peyrat L, Ciofu C, Haab F. Résultats à long terme après cure de prolapsus par voie vaginale par implantation de treillis Avaulta™ antérieur. Prog Urol 2014; 24:849-50. [DOI: 10.1016/j.purol.2014.08.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
12
|
Deffieux X, Fatton B, Denys P, Chartier-Kastler E, Amarenco G, Haab F, Costa P, Game X, Karsenty G, Saussine C, Ballanger P, Le Normand L, Ruffion A, Hermieu JF, Cosson M. [Intra-detrusor injection of botulinum toxin for female refractory idiopathic overactive bladder syndrome]. J Gynecol Obstet Hum Reprod 2014; 43:572-580. [PMID: 25087018 DOI: 10.1016/j.jgyn.2014.06.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2014] [Revised: 06/17/2014] [Accepted: 06/18/2014] [Indexed: 06/03/2023]
Abstract
INTRODUCTION Botulinum toxin-A detrusor injections are now approved for use (extension of marketing authorization) in the management of refractory idiopathic overactive bladder. The goal of the current study was to study the value and efficacy of this therapy. PATIENTS AND METHODS A literature review was performed on Medline, Embase and Cochrane databases, using the following keywords: botulinum toxin; overactive bladder syndrome; urinary incontinence; detrusor injection. RESULTS The recommended first step dose is 50 units of BOTOX(©) (dose selected for tolerance assessment). However, the cure rates for urge incontinence are greater with 100 units. Before proposing an injection, it is recommended to ensure the feasibility and acceptability of self-catheterisation by the patient, because of the risk of urinary retention (6%). The administration of BOTOX(©) comprises an intra-detrusor injection using a cystoscope, performed under local anesthesia. Clinical improvement is generally observed in the first two weeks after the injection. Patients should be considered for reinjection when the clinical effect of the previous injection has diminished, approximately 6-9 months after the first injection. An injection of 100 units may be considered when the clinical benefit of the 50-unit injection is not satisfactory concerning incontinence symptoms. CONCLUSION Botulinum toxin detrusor injections may be offered to women who develop refractory OAB.
Collapse
Affiliation(s)
- X Deffieux
- Service de gynécologie-obstétrique et médecine de la reproduction, hôpital Antoine-Béclère, groupe hospitalier universitaire Sud, Assistance publique-Hôpitaux de Paris (AP-HP), 157, rue de La-Porte-de-Trivaux, 92414 Clamart, France.
| | - B Fatton
- Service de gynécologie, CHRU Carémeau, rue du Professeur-Debré, 30029 Nîmes cedex 9, France
| | - P Denys
- Service de médecine physique et de réadaptation, hôpital Raymond-Poincaré, 104, boulevard Raymond-Poincaré, 92380 Garches, France
| | - E Chartier-Kastler
- Service d'urologie, hôpital de la Pitié-Salpétrière, 47-83, boulevard de l'Hôpital, 75013 Paris, France
| | - G Amarenco
- Service de rééducation neuro-urologique, hôpital Tenon, 4, rue de La-Chine, 75020 Paris, France
| | - F Haab
- Service d'urologie, hôpital Tenon, 4, rue de La-Chine, 75020 Paris, France
| | - P Costa
- Service d'urologie, CHRU Carémeau, rue du Professeur-Debré, 30029 Nîmes cedex 9, France
| | - X Game
- Service d'urologie, hôpital de Rangueil, 1, avenue du Professeur-Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France
| | - G Karsenty
- Service d'urologie, hôpital de la Conception, 147, boulevard Baille, 13005 Marseille, France
| | - C Saussine
- Service d'urologie, centre hospitalier universitaire, 1, place de l'Hôpital, 67000 Strasbourg, France
| | - P Ballanger
- Service d'urologie, hôpital Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France
| | - L Le Normand
- Service d'urologie, Hôtel-Dieu, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
| | - A Ruffion
- Service d'urologie, centre hospitalier Lyon Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France
| | - J-F Hermieu
- Service d'urologie, hôpital Bichat, 46, rue Henri-Huchard, 75018 Paris, France
| | - M Cosson
- Service de gynécologie, CHRU de Lille, rue Eugène-Avinée, 59037 Lille cedex, France
| |
Collapse
|
13
|
Hermieu JF, Ballanger P, Amarenco G, Chartier-Kastler É, Cosson M, Costa P, Fatton B, Saussine C, Denys P, Gamé X, Haab F, Karsenty G, Le Normand L, Ruffion A, Deffieux X. Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendations. Prog Urol 2014; 24:e1-7. [DOI: 10.1016/j.purol.2014.06.005] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2014] [Accepted: 06/12/2014] [Indexed: 11/16/2022]
|
14
|
Hermieu JF, Ballanger P, Amarenco G, Chartier-Kastler É, Cosson M, Costa P, Fatton B, Deffieux X, Denys P, Gamé X, Haab F, Karsenty G, Le Normand L, Ruffion A, Saussine C. Recommandations pour l’utilisation de la toxine botulinique de type A (Botox®) dans l’hyperactivité vésicale réfractaire idiopathique. Prog Urol 2013; 23:1457-63. [DOI: 10.1016/j.purol.2013.10.006] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2013] [Revised: 10/13/2013] [Accepted: 10/14/2013] [Indexed: 10/26/2022]
|
15
|
Cornu J, Wiedemann L, Haab E, Peyrat L, Beley S, Cathelineau X, Haab F. Implantation de sphincter urinaire artificiel chez l’homme par voie transcaverneuse comme procédure de sauvetage dans les cas complexes : résultats d’une série monocentrique. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.08.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
16
|
Cornu J, Lizée D, Peyrat L, Henry N, Ciofu C, Cussenot O, Haab F. Suivi à moyen terme après implantation de mini-bandelette Ajust™ pour le traitement de l’incontinence urinaire féminine : efficacité, complications et facteurs pronostiques. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.08.125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
17
|
Cornu J, Lizée D, Sèbe P, Doucet C, Ciofu C, Costa P, Gil Diez De Medina S, Amarenco G, Cussenot O, Pinset C, Haab F. Thérapie cellulaire de l’incontinence urinaire d’effort féminine par incompétence sphinctérienne par injection intrasphinctérienne de cellules musculaires autologues : résultats à 6ans de recul. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.08.148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
18
|
Haddad M, Cornu J, Henry N, Cussenot O, Sèbe P, Traxer O, Haab F. Néphro-urétérectomie d’emblée ou après tentative de traitement conservateur dans les tumeurs de la voie excrétrice supérieure : comparaison des résultats anatomopathologiques. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.08.252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
19
|
Lizée D, Cornu JN, Peyrat L, Ciofu C, Beley S, Haab F. Mini-bandelettes pour le traitement de l’incontinence urinaire d’effort féminine : revue de la littérature. Prog Urol 2013; 23:917-25. [DOI: 10.1016/j.purol.2013.07.008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2013] [Revised: 07/01/2013] [Accepted: 07/03/2013] [Indexed: 01/01/2023]
|
20
|
Haab F, Braticevici B, Krivoborodov G, Palmas M, Zufferli Russo M, Pietra C. Efficacy and safety of repeated dosing of netupitant, a neurokinin-1 receptor antagonist, in treating overactive bladder. Neurourol Urodyn 2013; 33:335-40. [PMID: 23765630 DOI: 10.1002/nau.22406] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2013] [Accepted: 03/04/2013] [Indexed: 01/23/2023]
Abstract
AIM NK-1 receptors in sensory nerves, the spinal cord and bladder smooth muscle participate in complex sensory mechanisms that regulate bladder activity. This study was designed to assess the efficacy and safety of a new NK-1 receptor antagonist, netupitant, in patients with OAB. METHODS This was a phase II, multicenter, double-blind study in which adults with OAB symptoms >6 months were randomized to receive 1 of 3 doses of netupitant (50, 100, 200 mg) or placebo once daily for 8 weeks. The primary efficacy endpoint was percentage change from baseline in average number of daily micturitions at week 8. Urinary incontinence, urge urinary incontinence (UUI), and urgency episodes were also assessed. RESULTS The primary efficacy endpoint was similar in the treatment groups (-13.85 for placebo to -16.17 in the netupitant 200 mg group) with no statistically significant differences between netupitant and placebo. The same was true for most secondary endpoints although a significant difference for improvement in UUI episodes and a trend for the greatest decrease in urgency episodes were seen in the netupitant 100 mg group. Netupitant was well tolerated with most treatment emergent adverse events (AEs) being mild. While the overall incidence of AEs increased with netupitant dose, there was no evidence for this dose dependency based on relationship to treatment, intensity, or time to onset. CONCLUSIONS The study failed to demonstrate superiority of netupitant versus placebo in decreasing OAB symptoms, despite a trend favoring netupitant 100 mg. There were no safety concerns with daily administration of netupitant over 8 weeks.
Collapse
Affiliation(s)
- F Haab
- Department of Urology, Hopital Tenon, Paris, France
| | | | | | | | | | | |
Collapse
|
21
|
Cornu JN, Haab F. Traitements pharmacologiques de l’hyperactivité vésicale idiopathique : revue de la littérature. Prog Urol 2013; 23:227-36. [DOI: 10.1016/j.purol.2013.02.001] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2012] [Revised: 02/02/2013] [Accepted: 02/04/2013] [Indexed: 01/16/2023]
|
22
|
Audenet F, Cancel-tassin G, Roupret M, Gaffory C, Azzouzi AR, Haab F, Bitker MO, Mejean A, Cussenot O. Rôle du polymorphisme génétique comme facteur de susceptibilité et d’agressivité du carcinome rénal à cellules claires. Prog Urol 2012. [DOI: 10.1016/j.purol.2012.08.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
23
|
Haab F, Fatton B, Bellessort A, Serikoff A. Prévalence et prise en charge des patients souffrant d’hyperactivité vésicale dans la population générale française en 2012. Prog Urol 2012. [DOI: 10.1016/j.purol.2012.08.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
24
|
Cornu JN, Terrasa JB, Cussenot O, Haab F, Lukacs B. Influence de la taille de la prostate sur les résultats de la photovaporisation laser de prostate : étude prospective sur 192 patients. Prog Urol 2012. [DOI: 10.1016/j.purol.2012.08.188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
25
|
Borrini L, Lukacs B, Ciofu C, Gaibisso B, Haab F, Amarenco G. [Predictive value of the penile cuff-test for the assessment of bladder outlet obstruction in men]. Prog Urol 2012; 22:657-64. [PMID: 22999091 DOI: 10.1016/j.purol.2012.07.017] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2012] [Revised: 07/27/2012] [Accepted: 07/30/2012] [Indexed: 11/17/2022]
Abstract
PURPOSE To assess the diagnostic performances and the acceptability of the penile cuff test (PCT) which is a non invasive method for the evaluation of bladder outlet obstruction (BOO), in comparison with the pressure flow study (PFS), the actual gold-standard. MATERIAL Monocentric prospective study comparing the following subsets: "obstructed", "not obstructed" or "equivocal", deduced from PFS vs PCT, in 30 consecutive patients presenting with lower urinary tract symptoms. For the PCT, a cuff placed around the penis inflated automatically during the micturition, until flow rate interruption. The interruption cuff pressure revealed the isovolumetric bladder pressure (Pcuff-int). The data collected - Pcuff-int and maximum flow rate - were automatically reported on ICS modified nomogram. RESULTS With the PFS, 11 patients (39%) were classified "obstructed", six patients (22%) "non-obstructed" and 11 patients (39%) "equivocal". In 61% cases, the patient was classified in the same category by both techniques. The "obstructed positive predictive value" of the PCT was 82% and the "non-obstructed-equivocal negative predictive value" was 88%. The median acceptability visual analogic scale score was 1/10 (0-3) for the PCT whereas it was 5/10 (2-10) for the PFS. This difference was statistically significant (p=0.004). CONCLUSION The PCT was a reliable non-invasive tool for the diagnosis of BOO in male, in comparison with PFS. The predictive values of the PCT were relevant and its tolerance was better than PFS.
Collapse
Affiliation(s)
- L Borrini
- Service de neuro-urologie et d'explorations pelvi-périnéales, hôpital Tenon, groupe de recherche clinique en neuro-urologie, université Pierre-et-Marie-Curie (GRC-UPMC-01), 4, rue de la Chine, 75970 Paris cedex 20, France.
| | | | | | | | | | | |
Collapse
|
26
|
Abdou A, Cornu JN, Sèbe P, Ciofu C, Peyrat L, Cussenot O, Haab F. [Salvage therapy with artificial urinary sphincter after Advance™ male sling failure for post-prostatectomy incontinence: a first clinical experience]. Prog Urol 2012; 22:650-6. [PMID: 22999090 DOI: 10.1016/j.purol.2012.06.011] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2012] [Revised: 06/18/2012] [Accepted: 06/30/2012] [Indexed: 11/17/2022]
Abstract
OBJECTIVES To assess the clinical outcome following artificial urinary sphincter (AUS) implantation after failure of Advance™ sub-urethral male sling for post-prostatectomy incontinence (PPI). METHODS A prospective evaluation was conducted about consecutive patients who received an AUS after failure of Advance™ therapy in one tertiary reference center. Evaluation included medical history, pad use and operative data (duration, cuff size, technical difficulties). Follow-up was scheduled at 1, 6, 12 months and yearly thereafter. Clinical outcome was evaluated by pad use, patient global impression of improvement (PGI-I) scale and assessment of side effects. Cure was defined as no pad usage. RESULTS Twelve patients were included in this evaluation. Median follow-up was 20 months (12-43). No patient was lost to follow-up. Four patients had a history of radiation therapy and all patients had mild or moderate PPI with previous failed Advance™ surgery. Median (range) operative time was 47 minutes (40-60). No technical problem occurred during AUS implantation. Hospital stay duration and catheterization duration were respectively 2 days and 24 hours in all but one case. At last follow-up, 10/12 patients (83%) were cured and fully satisfied. Two were improved, wearing only one pad per day. Postoperative complications were noted in two cases (17%) (one case of cutaneous erosion and one case of superficial iliac wound infection). CONCLUSIONS AUS implantation is feasible in patients who have undergone Advance™ male sling implantation. Mid-term results of this procedure are comparable to those obtained after first line AUS implantation.
Collapse
Affiliation(s)
- A Abdou
- Service d'urologie, université Pierre-et-Marie-Curie Paris 6, hôpital Tenon, groupe hospitalo-universitaire Est, AP-HP, 4, rue de la Chine, 75970 Paris cedex 20, France
| | | | | | | | | | | | | |
Collapse
|
27
|
Cornu JN, Doucet C, Sèbe P, Ciofu C, Gil Diez de Medina S, Vallancien G, Amarenco G, Cussenot O, Pinset C, Haab F. Évaluation prospective du traitement de l’incontinence urinaire post-prostatectomie par injections intrasphinctériennes de cellules musculaires autologues. Prog Urol 2011; 21:859-65. [DOI: 10.1016/j.purol.2011.03.001] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2010] [Revised: 01/29/2011] [Accepted: 03/04/2011] [Indexed: 10/15/2022]
|
28
|
Ben Saddik M, Al-Qahtani Sejiny S, Ndoye M, Gil-diez-de-Medina S, Merlet B, Thomas A, Haab F, Traxer O. Urétéroscopie souple dans le traitement des calculs du rein de 2 à 3cm. Prog Urol 2011; 21:327-32. [DOI: 10.1016/j.purol.2010.07.012] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2010] [Revised: 07/04/2010] [Accepted: 07/08/2010] [Indexed: 11/26/2022]
|
29
|
Chouaib A, Sebe P, Haab F, Tligui M. [Emphysematous pyelonephritis in a kidney allograft: indication for a secondary nephrectomy]. Med Mal Infect 2011; 41:443-5. [PMID: 21514754 DOI: 10.1016/j.medmal.2011.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2010] [Revised: 02/23/2011] [Accepted: 03/16/2011] [Indexed: 11/26/2022]
|
30
|
Amarenco G, Haab F, Touboul C, Guillaume X, Coloby P, Cosson M, Plisson C, Grivel T. État des lieux de l’incontinence urinaire en France chez les femmes de 35 ans et plus. ACTA ACUST UNITED AC 2010. [DOI: 10.1007/s11608-010-0352-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
31
|
Cornu J, Terrasa J, Tligui M, Sèbe P, Peyrat L, Ciofu C, Traxer O, Cussenot O, Haab F, Lukacs B. UP-1.36: Definitive assessment of early post-operative symptoms after laser photovaporization of the prostate (PVP): validation of a dedicated questionnaire. Urology 2010. [DOI: 10.1016/j.urology.2010.07.169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
32
|
Cornu JN, Merlet B, Cussenot O, Cancel-Tassin G, Ciofu C, Amarenco G, Haab F. Genetic susceptibility to urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways. World J Urol 2010; 29:239-42. [DOI: 10.1007/s00345-010-0585-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2010] [Accepted: 07/05/2010] [Indexed: 10/19/2022] Open
|
33
|
Fritel X, Fauconnier A, Bader G, Cosson M, Debodinance P, Deffieux X, Denys P, Dompeyre P, Faltin D, Fatton B, Haab F, Hermieux JF, Kerdraon J, Mares P, Mellier G, Michel-Laaengh N, Nadeau C, Robain G, de Tayrac R, Jacquetin B. Diagnostic et prise en charge de l’incontinence urinaire d’effort de la femme adulte. Recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF). ACTA ACUST UNITED AC 2010. [DOI: 10.1007/s11608-010-0321-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
34
|
Wagner L, Boileau L, Delmas V, Haab F, Costa P. Erratum à « Traitement chirurgical du prolapsus par promontofixation cœlioscopique. Techniques et résultats » [Prog Urol 2009;19:994–1005]. Prog Urol 2010. [DOI: 10.1016/j.purol.2010.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
35
|
Abstract
Rectocele is a rectal hernia through the posterior vaginal wall. There is three levels of rectocele. High rectocele is caused by the uterosacral and cardinal ligaments stretching; it needs prerecti fascia placation with a sacrofixation of an associated prolapsus of uterus or vaginal vault. The middle rectocele is linked with a rectovaginal fascia defect; the preferential choice for middle rectocele is midline fascial plication; superior myoraphy gives dyspareunia. The inferior rectocele results of a destruction of the perineal body; the treatment is a myoraphy with vulvoraphy. Complete rectocele would be an indication for a posterior mesh.
Collapse
Affiliation(s)
- A Cortesse
- Service d'Urologie, Hôpital Saint-Louis, AP-HP, 1 Avenue Claude-Vellefaux, 75010 Paris, France.
| | | | | | | |
Collapse
|
36
|
de Tayrac R, Letouzey V, Costa P, Haab F, Delmas V. [Treatment of uterine prolapse and vaginal vault by vaginal route]. Prog Urol 2009; 19:1074-9. [PMID: 19969278 DOI: 10.1016/j.purol.2009.09.025] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2009] [Accepted: 09/28/2009] [Indexed: 11/16/2022]
Abstract
All the prolapses of the median compartment (uterine or vault prolapse) of the pelvis have the same physiopathology. The surgical treatment must be reserved to symptomatic patients. Hysterectomy is discussed. The gold standard of the vaginal way is the sacrospinofixation (Richter procedure) Many other procedures are possible: colpofixation or colpocléisis. On young premenopausal women, the abdominal sacrofixation is the gold standard, but in postmenopausal ones, the vaginal way, specially the sacrospinofixation, is quicker and with less morbidity and hospitalization.
Collapse
Affiliation(s)
- R de Tayrac
- Service de Gynécologie, Hôpital Carémeau, CHU de Nîmes, Université Montpellier I, Montpellier, France.
| | | | | | | | | |
Collapse
|
37
|
Haab F, Costa P, Delmas V. [Treatment of genitourinary prolapse]. Prog Urol 2009; 19:1098-102. [PMID: 19969281 DOI: 10.1016/j.purol.2009.09.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2009] [Accepted: 09/28/2009] [Indexed: 10/20/2022]
Abstract
Surgical treatment of genitourinary prolapse has changed considerably over the last few years. Now numerous surgical options are available offering efficient therapeutic solutions to treat different clinical situations. The type of surgical treatment depends on the precise analysis of the functional complaint and of anatomical pelvic lesions. The proposed treatment must take all aspects of the pathology into account. However, a review of existing research shows that there are still improvements to be made when it comes to comparing different techniques with one another.
Collapse
Affiliation(s)
- F Haab
- Service d'Urologie, Hôpital Tenon, Faculté de Médecine, Université Pierre-et-Marie-Curie, 4, rue de la Chine, 75020 Paris, France.
| | | | | |
Collapse
|
38
|
Ragni E, Lousquy R, Costa P, Delmas V, Haab F. Facteurs de risque et prévention des prolapsus génito-urinaires. Prog Urol 2009; 19:932-8. [DOI: 10.1016/j.purol.2009.09.021] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2009] [Accepted: 09/24/2009] [Indexed: 11/15/2022]
|
39
|
Fatton B, Wagner L, Delmas V, Haab F, Costa P. Place de l’hystérectomie lors de la cure de prolapsus par promontofixation. Prog Urol 2009; 19:1006-13. [DOI: 10.1016/j.purol.2009.09.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2009] [Accepted: 09/21/2009] [Indexed: 11/25/2022]
|
40
|
Lapray JF, Costa P, Delmas V, Haab F. Rôle de l’échographie dans l’exploration des troubles de la statique pelvienne. Prog Urol 2009; 19:947-52. [DOI: 10.1016/j.purol.2009.09.017] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2009] [Accepted: 09/17/2009] [Indexed: 10/20/2022]
|
41
|
Wagner L, Boileau L, Delmas V, Haab F, Costa P. Traitement chirurgical du prolapsus par promontofixation cœlioscopique. Techniques et résultats. Prog Urol 2009; 19:994-1005. [DOI: 10.1016/j.purol.2009.09.026] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2009] [Accepted: 09/21/2009] [Indexed: 10/20/2022]
|
42
|
Lapray JF, Costa P, Delmas V, Haab F. Rôle de l’imagerie dans l’exploration des troubles de la statique pelvienne. Prog Urol 2009; 19:953-69. [DOI: 10.1016/j.purol.2009.09.029] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2009] [Accepted: 09/17/2009] [Indexed: 10/20/2022]
|
43
|
|
44
|
|
45
|
Delmas V, Haab F, Costa P. Cystocèle : place des implants de renforcement par voie vaginale. Prog Urol 2009; 19:1025-30. [DOI: 10.1016/j.purol.2009.10.013] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2009] [Accepted: 10/26/2009] [Indexed: 11/26/2022]
|
46
|
Ragni E, Haab F, Delmas V, Costa P. Physiopathologie des prolapsus génito-urinaires. Prog Urol 2009; 19:926-31. [DOI: 10.1016/j.purol.2009.09.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2009] [Accepted: 09/22/2009] [Indexed: 10/20/2022]
|
47
|
Wagner L, Macia F, Delmas V, Haab F, Costa P. Traitement chirurgical du prolapsus par promontofixation par laparotomie. Prog Urol 2009; 19:988-93. [DOI: 10.1016/j.purol.2009.09.024] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2009] [Accepted: 09/21/2009] [Indexed: 11/26/2022]
|
48
|
Cornu J, Sèbe P, Ciofu C, Doucet C, Pinset C, Costa P, Vallancien G, Cussenot O, Haab F. POD-01.06: Monocentric Study of Feasibility and Safety of Intra-Sphincter Injections of Autologous Progenitor Muscular Cells in Patients with Urinary Incontinence Due To Sphincter Failure Following Radical Prostatectomy. Urology 2009. [DOI: 10.1016/j.urology.2009.07.1211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
49
|
Chartier-Kastler E, Leger D, Montauban V, Comet D, Haab F. Étude observationnelle nationale (Association française d’urologie) de l’impact de la nycturie sur le sommeil des patients porteurs d’une hyperplasie bénigne de la prostate. Prog Urol 2009; 19:333-40. [PMID: 19393539 DOI: 10.1016/j.purol.2008.10.013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2008] [Revised: 10/12/2008] [Accepted: 10/28/2008] [Indexed: 10/21/2022]
|
50
|
Henry N, Rouprêt M, Ciofu C, Gattegno B, Thibault P, Haab F, Beley S. [Management of premature ejaculation in adults]. Prog Urol 2008; 18:566-9. [PMID: 18986627 DOI: 10.1016/j.purol.2008.03.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2008] [Accepted: 03/29/2008] [Indexed: 10/21/2022]
Abstract
Premature ejaculation is a very frequent form of sexual dysfunction characterized by loss of control of ejaculation, inducing performance anxiety and, consequently, impaired quality of life of patients and their partners. The pathophysiology of this symptom is often both psychogenic and organic. The various organic causes must be systematically investigated. Several drug treatments are used with varying degrees of efficacy and their adverse effects must be taken into account when choosing a molecule. Psychological management is an essential complement to drug treatment.
Collapse
Affiliation(s)
- N Henry
- Service d'urologie, hôpital Tenon, AP-HP, groupe hospitalo-universitaire Est, faculté de médecine Pierre-et-Marie-Curie, université Paris-VI, 4, rue de la Chine, 75020 Paris, France
| | | | | | | | | | | | | |
Collapse
|